Nevro Corp. Common Stock (NVRO)

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Nevro stock rises as it gains CE Mark for its HFX iQ SCS system, the first with AI-based personalized pain relief. 2024 revenue outlook raised amid positive earnings.

Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!

NVRO stock results show that Nevro beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.